| Cash and cash equivalents |
5.22M |
| Receivables |
790.66K |
| Prepaid expenses |
| Inventory used for R&D and manufacturing |
1.26M |
| Deferred rent - current portion |
| Total current assets |
8.58M |
| RESEARCH AND OFFICE EQUIPMENT AND LEASEHOLD IMPROVEMENTS-- Less accumulated depreciation of $2,964,161 and $2,626,759 |
250.55K |
| PATENT COSTS- less accumulated amortization of $1,267,104 and $1,205,690 |
266.49K |
| RESTRICTED CASH |
| DEFERRED RENT - net of current portion |
3.57M |
| TOTAL ASSETS |
14.48M |
| Accounts payable |
4.44M |
| Accrued expenses |
520.97K |
| Due to employees |
316.8K |
| Related party loan |
0 |
| Convertible notes |
| Convertible preferred stock - 3,033 shares outstanding |
| Derivative instruments - current portion |
| Total current liabilities |
5.28M |
| Derivative instruments - net of current portion |
| Deferred revenue |
126.5K |
| Deferred rent |
18.38K |
| Total liabilities |
18.25M |
| Preferred stock, $.01 par value; authorized, 200,000 shares; no shares issued and outstanding |
0 |
| Common stock, $.01 par value; authorized, 450,000,000 shares; issued and outstanding, 210,584,868 and 204,868,853 shares at June 30, 2011 and September 30, 2010, respectively |
1.45M |
| Additional paid-in capital |
279.33M |
| Accumulated deficit |
-284.55M |
| Total stockholders' equity |
-3.77M |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
14.48M |
